Abstract
(2 in dCRT VS 1 in non-dCRT group), 4 pneumonia and 3 GI hemorrhage. Overall complication rate was higher in dCRT group (55% VS 19% with p valueZ 0.017). Four patients (9.7%) had mild retrosternal pain. Recurrent dysphagia occurred in 14 patients (34.14% )[7 stent migrations and 7 tumor ingrowths]. Mean duration of recurrent dysphagia symptom after stent placement was 81 days (121.5 vs 18 days, dCRT vs non dCRT, respectively, pZ0.022). Overall survival was 102.11 days (106.55 in dCRT VS 92.78 days in non-dCRT with pZ 0.189). Conclusion: SEMs placement combined with definite chemoradiation is effective for palliation of dysphagia in advanced esophageal cancer. Dysphagia-free interval after SEMs placements was significantly longer after dCRT compared to those without. However, incidence of esophageal perforation and overall complication seem higher in SEMs after dCRT.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
